Back to Journals » OncoTargets and Therapy » Volume 14

Chrysin Induced Cell Apoptosis and Inhibited Invasion Through Regulation of TET1 Expression in Gastric Cancer Cells [Corrigendum]

Authors Zhong X, Liu D, Jiang Z, Li C, Chen L, Xia Y, Liu D, Yao Q, Wang D

Received 15 January 2021

Accepted for publication 15 January 2021

Published 26 January 2021 Volume 2021:14 Pages 697—698

DOI https://doi.org/10.2147/OTT.S302177


Zhong X, Liu D, Jiang Z, et al. Onco Targets Ther. 2020;13:3277–3287

The authors have advised Figure 2E on page 3281 is incorrect. The migration of cells after chrysin treatment between 12 h and 24 h were very close, so the error was not identified. A recent check of the original data by the authors found this error. The correct Figure 2 is shown below.

The authors apologize for this error and advise it does not affect the results of the paper.


Read the original article

Zhong X, Liu D, Jiang Z, et al. Onco Targets Ther. 2020;13:3277–3287

The authors have advised Figure 2E on page 3281 is incorrect. The migration of cells after chrysin treatment between 12 h and 24 h were very close, so the error was not identified. A recent check of the original data by the authors found this error. The correct Figure 2 is shown below.

Figure 2 Analysis of cell apoptosis, cell cycle, and cell migration and invasion in GC cells. Cell apoptosis was analyzed after treatment with Chrysin (A). Statistical analysis of the percentage of cell apoptosis (B). The cell cycle was analyzed after treatment with Chrysin (C). Statistical analysis of the percentage of cells in the major phases of the cell cycle (D). Cell migration was analyzed after treatment with Chrysin (b). Statistical analysis of cell migration with wound closure assay (F). The cell invasion was analyzed after treatment with Chrysin (G). Statistical analysis of the cell invasion (H). *(p < 0.05), **(p < 0.01) and ***(p < 0.005) indicate statistically significant differences.

The authors apologize for this error and advise it does not affect the results of the paper.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]